Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
about
The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective StrategiesIschaemic postconditioning: cardiac protection after the eventIschaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryThe Mitochondrial Permeability Transition Pore Regulator Cyclophilin D Exhibits Tissue-Specific Control of Metabolic Homeostasis.Popeye domain containing 1 (Popdc1/Bves) is a caveolae-associated protein involved in ischemia toleranceAlcohol and thiamine deficiency trigger differential mitochondrial transition pore opening mediating cellular deathCrosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectivesFunctional and pharmacological characteristics of permeability transition in isolated human heart mitochondria.Modulation of intracellular calcium waves and triggered activities by mitochondrial ca flux in mouse cardiomyocytes.Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen speciesThe permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation.ROS-p53-cyclophilin-D signaling mediates salinomycin-induced glioma cell necrosisMitochondrial calcium and reactive oxygen species regulate agonist-initiated platelet phosphatidylserine exposureCypD(-/-) hearts have altered levels of proteins involved in Krebs cycle, branch chain amino acid degradation and pyruvate metabolismMitochondrial therapeutics for cardioprotection.Autophagy: an affair of the heartMK-2206, an AKT inhibitor, promotes caspase-independent cell death and inhibits leiomyoma growth.Cyclophilin D Is Involved in the Regulation of Autophagy and Affects the Lifespan of P. anserina in Response to Mitochondrial Oxidative Stress.Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.Redox balance and cardioprotection.Mitochondrial potassium channels as pharmacological target for cardioprotective drugs.Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1.Edaravone protects osteoblastic cells from dexamethasone through inhibiting oxidative stress and mPTP opening.P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts.Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology.Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells.Mitochondrial ROS production and subsequent ERK phosphorylation are necessary for temperature preconditioning of isolated ventricular myocytes.Cyclophilin D ablation is associated with increased end-ischemic mitochondrial hexokinase activity.Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart.Mitochondrial Cyclophilin D as a Potential Therapeutic Target for Ischemia-Induced Facial Palsy in Rats.Enhanced cell-volume regulation in cyclosporin A cardioprotection.HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/mPTP pathway.
P2860
Q26747310-CA6EB55F-BB5F-44F5-99D9-66716A9DF539Q26853129-D0E88DAA-8658-4C48-9B08-07B443F7E23AQ28072918-C70A0AF0-D6FC-47F6-8C03-1E964D38BD61Q28354143-83745F75-6F8B-4965-B166-838B304EAE2AQ28509630-4E31B5F8-4430-4DE7-974A-8FAE3548078DQ29994621-D5312502-0BC2-4A1C-B112-07C045066795Q34289211-82BA8AEC-DFA5-40B9-B2CB-2B7E9D1BCB5CQ34807984-F2271390-645B-477A-BA23-0B1A5D7F142EQ35069326-3A1BB19F-8CD2-4335-80B7-C51F8A5AF40EQ35113412-9E21CE3F-B427-4BA7-8A0E-56B600FC94A7Q35218361-F3C00BBC-3DAD-448E-A9CF-EC7634B6558FQ35801577-5B62D5AA-6595-465B-B281-93A5B722C003Q36534692-9AE255A8-23D0-4952-9DB5-26CE149DDA9EQ36630500-FBCBAE7E-5AF5-4D01-A2DB-3CF6E0D9FCF5Q37152171-D45807A4-92B8-4CB0-87FD-C4BE68A4555AQ37196353-4FBAD21D-B84F-4CF3-9B35-8D01E48FBD30Q37240206-E157326F-55D1-4F55-881F-1C5F604FCC8EQ37253483-17DF5A8F-AA51-454A-B6DE-FEAE57D41210Q38137849-6E0EF4D3-8FBB-47E5-9795-8A7527DAAD21Q38155452-1F044934-534D-42B5-83AD-1CA748FECC57Q38262884-316A086B-C14E-40EB-BE21-E608222AD0F1Q38370240-5BA1A9F1-7580-4852-96C9-3FBBA0412203Q38847653-D0C81702-3FF5-470E-AEAE-8EC6A9BA2AE1Q38852430-71D47BCD-A53C-4360-9F6E-0FE95FC61DC2Q39016683-10263D26-C563-45FA-9F89-C97A50C972F3Q39169425-DA675642-2D64-4877-ABC3-EDA175E05ED9Q40477152-DD579C2E-2806-4E74-8309-435BB10C5B9BQ42087820-0B3CB645-4138-45B1-83C7-D2CA760DAACFQ42371836-D1C5E21E-D565-4C5C-B0D3-A32148D81F58Q47216016-94BE9DEC-ED58-46F8-A27D-AED76D215EDAQ48256725-5A4BE21F-0E5A-40BB-8538-F83C0CDC16B8Q50236357-FD3F2F3D-AD07-440E-A06D-ED28E3D204B6Q54334859-BA6FEE2F-72A6-41D6-8A3D-FD1CAA2E4A44Q55260529-C0612A05-4D8A-4FA0-B242-5CD590AD3DC6
P2860
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@ast
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@en
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@nl
type
label
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@ast
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@en
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@nl
prefLabel
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@ast
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@en
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@nl
P2860
P50
P356
P1476
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
@en
P2093
Sang-Ging Ong
Shiang Y Lim
P2860
P356
10.1093/CVR/CVQ113
P577
2010-04-16T00:00:00Z